A new generation of monoclonal antibodies arrives at the clinic

Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.

Internal medicine journal·2016

Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.

Internal medicine journal·2014

Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.

Journal of the National Cancer Institute·2026

Foundation models for cancer: advancing diagnosis, prognosis, and treatment response-an NCI workshop report.

Journal of the National Cancer Institute·2026

Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling study.

Journal of the National Cancer Institute·2026

Novel framework for the validation of intermediate clinical endpoints in oncology real-world data.

Journal of the National Cancer Institute·2026

Time trends of human papillomavirus-attributable head and neck cancers: the BROADEN study.

Journal of the National Cancer Institute·2026

Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

Journal of the National Cancer Institute·2026

Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China.

Frontiers in public health·2026

IL-2 and CD40L can establish and sustain a human B cell-mediated immune regulatory network.

bioRxiv : the preprint server for biology·2026

A 28-color panel for classical and non-classical T lymphocytes in decidua and PBMC in rhesus macaques.

bioRxiv : the preprint server for biology·2026

[pMHCBind: predicting major histocompatibility complex class I-peptide interactions via protein large language models and hypergraph neural networks].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2026

Current and Emerging Therapies for Generalized Myasthenia Gravis: Toward Precision Medicine.

Neurology and therapy·2026

Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study.

Rheumatology and therapy·2026

Related Experiment Videos

A new generation of monoclonal antibodies arrives at the clinic

Related Concept Videos

Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.

Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.

Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.

Foundation models for cancer: advancing diagnosis, prognosis, and treatment response-an NCI workshop report.

Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling study.

Novel framework for the validation of intermediate clinical endpoints in oncology real-world data.

Time trends of human papillomavirus-attributable head and neck cancers: the BROADEN study.

Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China.

IL-2 and CD40L can establish and sustain a human B cell-mediated immune regulatory network.

A 28-color panel for classical and non-classical T lymphocytes in decidua and PBMC in rhesus macaques.

[pMHCBind: predicting major histocompatibility complex class I-peptide interactions via protein large language models and hypergraph neural networks].

Current and Emerging Therapies for Generalized Myasthenia Gravis: Toward Precision Medicine.

Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study.

Related Experiment Videos

A new generation of monoclonal antibodies arrives at the clinic

Related Concept Videos

Related Articles